Product Details for: Degevma
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
120MG/1.7ML (70MG/ML)
Single-Dose Vial
351(k) Interchangeable
Degevma
Rx
Proper Name
denosumab-adet
denosumab-adet
Reference Product Proper Name
denosumab
denosumab
Reference Product Properietary Name
Xgeva
Xgeva
BLA Number
761481
761481
Applicant
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc.
Original Approval Date
September 25, 2026
September 25, 2026
Date of First Licensure